MAR 24, 2022 10:00 AM PDT

Oncotopix Discovery: deep learning as a standard analysis method for digital pathology images

Sponsored by: Visiopharm®
Speakers

Abstract
Date:  March 24, 2022
Time: 10:00am (PDT),  1:00pm (EDT), 7:00pm (CET)
 
Easy-to-use AI-based deep learning is now integrated as the standard analysis methodology in our best-in-class analysis software. Designed for anyone, it allows tissue-based researchers to tackle both simple and complex datasets across a wide variety of applications. In the past, only image analysis experts could analyse complex tissues. Our new analysis packages include powerful pre-trained nuclei segmentation algorithms suitable for brightfield and fluorescence applications which can be further tuned for even more specificity, and deep-learning-based tissue segmentation to find tissues of interest, exclude artifacts, and enable scoring/counting within specific tissue compartments. Now, anyone with the understanding of tissue morphology can train an AI-based deep learning network to get accurate and reproducible data, making it easy to generate reliable quantitative results needed for breakthrough discoveries and publications.
 
Learning Objectives
  • How the use of deep learning improves the analysis of digital pathology images
  • The use of deep learning to segment tissues, find artifacts, and localize scoring/counting to specific regions of tissue
  • Using pre-trained deep learning networks to segment nuclei across a range of tissue and staining types
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
NOV 30, 2021 11:00 AM PST
C.E. CREDITS
NOV 30, 2021 11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
Loading Comments...
Show Resources